GlassScriptPhysician profile
Carlos V Bernal
NPI 1114080173
$1,076.33
in general payments reported to CMS, 2019-2025
16 companies · $787 in 2025
The $787 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.35 · 2021: $14.71 · 2023: $18.59 · 2024: $243 · 2025: $787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,048.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $172.94 | 2024-2025 | Farxiga, Breztri |
| Inspire Medical Systems, INC. | $135.56 | 2024-2025 | Inspire |
| Amgen INC. | $132.80 | 2025 | Repatha, Otezla, Krystexxa |
| Glaxosmithkline, LLC. | $103.12 | 2023-2025 | Bexsero, Shingrix, Arexvy |
| Pfizer INC. | $80.20 | 2025 | |
| Novo Nordisk INC | $77.49 | 2020-2025 | Ozempic |
| Lilly USA, LLC | $74.60 | 2024-2025 | Zepbound, Mounjaro |
| Exact Sciences Corporation | $53.87 | 2024-2025 | Cologuard Collection Kit |
| Verity Pharmaceuticals INC. | $49.65 | 2025 | Tlando |
| Merck Sharp & Dohme LLC | $43.72 | 2024-2025 | Capvaxive, Gardasil 9, Gardasil |
| Boston Scientific Corporation | $29.77 | 2024 | Watchman Flx |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.41 | 2024-2025 | Xifaxan |
| Otsuka America Pharmaceutical, INC. | $28.27 | 2025 | Rexulti |
| Esperion Therapeutics, INC. | $23.38 | 2025 | Nexletol |
| Xeris Pharmaceuticals, INC. | $23.22 | 2024 | Keveyis |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $18.33 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Bernal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.